Share this:
Published on: June 22, 2017 at 12:00PM
Conditions: Triple Negative Breast Cancer; Triple Negative Breast Neoplasms; TNBC – Triple-Negative Breast Cancer; Triple-negative Breast Carcinoma
Interventions: Drug: Durvalumab; Biological: Neoantigen DNA vaccine; Device: TDS-IM system (Inchor Medical Systems); Procedure: Peripheral blood draw
Sponsors: Washington University School of Medicine; MedImmune LLC
Not yet recruiting – verified June 2017
http://ift.tt/2u8nQNz
More Stories
‘My 401k Misses You’: Black Woman Pumped To Meet Donald Trump In Philadelphia – July 18, 2023 at 04:56PM
Energy Provider Warns of Impending ‘Crisis,’ ‘Blackout Conditions’ Driven By Biden Plans – July 18, 2023 at 04:20PM
Dog starts barking at cows crossing a bridge, so the cows stop to have a look. – July 17, 2023 at 02:27PM